Form 8-K - Current report:
SEC Accession No. 0001193125-22-135307
Filing Date
2022-05-02
Accepted
2022-05-02 07:06:00
Documents
31
Period of Report
2022-05-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d232851d8k.htm   iXBRL 8-K 25943
2 EX-99.1 d232851dex991.htm EX-99.1 15600
6 GRAPHIC g232851ex99_1s10g1.jpg GRAPHIC 249359
7 GRAPHIC g232851ex99_1s11g1.jpg GRAPHIC 291850
8 GRAPHIC g232851ex99_1s12g1.jpg GRAPHIC 202368
9 GRAPHIC g232851ex99_1s13g1.jpg GRAPHIC 246041
10 GRAPHIC g232851ex99_1s14g1.jpg GRAPHIC 175841
11 GRAPHIC g232851ex99_1s15g1.jpg GRAPHIC 151931
12 GRAPHIC g232851ex99_1s16g1.jpg GRAPHIC 374851
13 GRAPHIC g232851ex99_1s17g1.jpg GRAPHIC 308498
14 GRAPHIC g232851ex99_1s18g1.jpg GRAPHIC 68919
15 GRAPHIC g232851ex99_1s1g1.jpg GRAPHIC 104440
16 GRAPHIC g232851ex99_1s2g1.jpg GRAPHIC 350972
17 GRAPHIC g232851ex99_1s3g1.jpg GRAPHIC 208306
18 GRAPHIC g232851ex99_1s4g1.jpg GRAPHIC 344631
19 GRAPHIC g232851ex99_1s5g1.jpg GRAPHIC 424440
20 GRAPHIC g232851ex99_1s6g1.jpg GRAPHIC 361849
21 GRAPHIC g232851ex99_1s7g1.jpg GRAPHIC 233588
22 GRAPHIC g232851ex99_1s8g1.jpg GRAPHIC 282893
23 GRAPHIC g232851ex99_1s9g1.jpg GRAPHIC 291761
  Complete submission text file 0001193125-22-135307.txt   6609269

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tars-20220502.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tars-20220502_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tars-20220502_pre.xml EX-101.PRE 11701
25 EXTRACTED XBRL INSTANCE DOCUMENT d232851d8k_htm.xml XML 3477
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 22879356
SIC: 2836 Biological Products, (No Diagnostic Substances)